BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21253654)

  • 1. Probing the acceptor substrate binding site of Trypanosoma cruzi trans-sialidase with systematically modified substrates and glycoside libraries.
    Harrison JA; Kartha KP; Fournier EJ; Lowary TL; Malet C; Nilsson UJ; Hindsgaul O; Schenkman S; Naismith JH; Field RA
    Org Biomol Chem; 2011 Mar; 9(5):1653-60. PubMed ID: 21253654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi trans-sialidase alternative substrates: Study of the effect of substitution in C-6 in benzyl β-lactoside.
    Morrone-Pozzuto P; Uhrig ML; Agusti R
    Carbohydr Res; 2019 May; 478():33-45. PubMed ID: 31054381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
    Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
    Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of primary structure modifications in Trypanosoma cruzi neuraminidase/trans-sialidase activities.
    Cremona ML; Pollevick GD; Frasch AC; Campetella O
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):697-702. PubMed ID: 8832101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous nonradioactive method for screening trypanosomal trans-sialidase activity and its inhibitors.
    Sartor PA; Agusti R; Leguizamón MS; Campetella O; de Lederkremer RM
    Glycobiology; 2010 Aug; 20(8):982-90. PubMed ID: 20375068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
    Meinke S; Schroven A; Thiem J
    Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and enzymatic evaluation of 3-O-substituted aryl β-D-galactopyranosides as inhibitors of Trypanosoma cruzi trans-sialidase.
    Silva BL; S Filho JD; Andrade P; Carvalho I; Alves RJ
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4529-4532. PubMed ID: 25149510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR spectroscopic and molecular modeling investigations of the trans-sialidase from Trypanosoma cruzi.
    Haselhorst T; Wilson JC; Liakatos A; Kiefel MJ; Dyason JC; von Itzstein M
    Glycobiology; 2004 Oct; 14(10):895-907. PubMed ID: 15190004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of catalytic function by differential plasticity of the active site: case study of Trypanosoma cruzi trans-sialidase and Trypanosoma rangeli sialidase.
    Demir O; Roitberg AE
    Biochemistry; 2009 Apr; 48(15):3398-406. PubMed ID: 19216574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi Trans-sialidase: structural features and biological implications.
    Oliveira IA; Freire-de-Lima L; Penha LL; Dias WB; Todeschini AR
    Subcell Biochem; 2014; 74():181-201. PubMed ID: 24264246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The trans-sialidase from Trypanosoma cruzi efficiently transfers alpha-(2-->3)-linked N-glycolylneuraminic acid to terminal beta-galactosyl units.
    Agustí R; Giorgi ME; de Lederkremer RM
    Carbohydr Res; 2007 Nov; 342(16):2465-9. PubMed ID: 17765882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the activity and specificity of Trypanosoma cruzi trans-sialidase from molecular dynamics simulations.
    Mitchell FL; Neres J; Ramraj A; Raju RK; Hillier IH; Vincent MA; Bryce RA
    Biochemistry; 2013 May; 52(21):3740-51. PubMed ID: 23672572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of e-pharmacophore models using compound fragments for the trans-sialidase of Trypanosoma cruzi: screening for novel inhibitor scaffolds.
    Miller BR; Roitberg AE
    J Mol Graph Model; 2013 Sep; 45():84-97. PubMed ID: 24012872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactosyl-lactose sialylation using Trypanosoma cruzi trans-sialidase as the biocatalyst and bovine κ-casein-derived glycomacropeptide as the donor substrate.
    Wilbrink MH; ten Kate GA; van Leeuwen SS; Sanders P; Sallomons E; Hage JA; Dijkhuizen L; Kamerling JP
    Appl Environ Microbiol; 2014 Oct; 80(19):5984-91. PubMed ID: 25063655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi trans-sialidase. A tool for the synthesis of sialylated oligosaccharides.
    Agusti R; Gallo-Rodriguez C; de Lederkremer RM
    Carbohydr Res; 2019 Jun; 479():48-58. PubMed ID: 31132642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosomal Trans-sialidases: Valuable Synthetic Tools and Targets for Medicinal Chemistry.
    Meinke S; Thiem J
    Top Curr Chem; 2015; 367():231-50. PubMed ID: 22648866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a model trisaccharide for studying the interplay between the anti α-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi.
    Giorgi ME; Lopez R; Agusti R; Marino C; de Lederkremer RM
    Carbohydr Res; 2017 Oct; 450():30-37. PubMed ID: 28858610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the differences of the hydrolytic activity of Trypanosoma cruzi trans-sialidase and Trypanosoma rangeli sialidase: a quantum mechanics-molecular mechanics modeling study.
    Bueren-Calabuig JA; Pierdominici-Sottile G; Roitberg AE
    J Phys Chem B; 2014 Jun; 118(22):5807-16. PubMed ID: 24814976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its comparison with T. cruzi trans-sialidase.
    Amaya MF; Buschiazzo A; Nguyen T; Alzari PM
    J Mol Biol; 2003 Jan; 325(4):773-84. PubMed ID: 12507479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatically inactive trans-sialidase from Trypanosoma cruzi binds sialyl and beta-galactopyranosyl residues in a sequential ordered mechanism.
    Todeschini AR; Dias WB; Girard MF; Wieruszeski JM; Mendonça-Previato L; Previato JO
    J Biol Chem; 2004 Feb; 279(7):5323-8. PubMed ID: 14634017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.